Diabetes Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Diabetes stocks.

Diabetes Stocks Recent News

Date Stock Title
May 10 PODD Insulet Corporation (NASDAQ:PODD) Q1 2024 Earnings Call Transcript
May 10 APLT Applied Therapeutics Inc (APLT) Reports Q1 2024 Earnings: A Deep Dive into Financials and ...
May 10 PODD Insulet Corp (PODD) Reports Strong Q1 2024 Results and Raises Full-Year Guidance
May 10 OCUP Ocuphire Pharma GAAP EPS of -$0.29 misses by $0.20, revenue of $1.71M misses by $2.96M
May 10 OCUP Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update
May 10 PODD Insulet Corporation 2024 Q1 - Results - Earnings Call Presentation
May 10 PODD Insulet Corporation (PODD) Q1 2024 Earnings Call Transcript
May 9 PODD Here's What Key Metrics Tell Us About Insulet (PODD) Q1 Earnings
May 9 PODD Insulet Non-GAAP EPS of $0.23 misses by $0.16, revenue of $441.7M beats by $18.21M
May 9 PODD Insulet Reports First Quarter 2024 Revenue Increase of 23% Year-Over-Year
May 9 PODD Nvidia, Micron and Super Micro among companies that shine in Wall Street’s ‘beat-and-raise’ game
May 9 VKTX Viking Therapeutics: The Metabolic Masterpiece Primed To Be Acquired
May 9 RANI Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024
May 9 APLT Applied Therapeutics GAAP EPS of -$0.67 misses by $0.51
May 9 LXRX Lexicon Pharmaceuticals to Participate in the Bank of America Securities Healthcare Conference 2024
May 9 APLT Applied Therapeutics Reports First Quarter 2024 Financial Results
May 9 RANI RANI: 1Q:24 Results
May 8 PODD Insulet Q1 2024 Earnings Preview
May 8 INBS Intelligent Bio Solutions GAAP EPS of -$1.43 misses by $0.56, revenue of $0.82M misses by $0.37M
May 8 INBS Intelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results and Operational Highlights
Diabetes

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. There are three main types of diabetes mellitus:
Type 1 DM results from the pancreas' failure to produce enough insulin due to loss of beta cells. This form was previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". The cause is unknown.
Type 2 DM begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses, a lack of insulin may also develop. This form was previously referred to as "non insulin-dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". The most common cause is a combination of excessive body weight and insufficient exercise.
Gestational diabetes is the third main form, and occurs when pregnant women without a previous history of diabetes develop high blood sugar levels.Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM. Gestational diabetes usually resolves after the birth of the baby.As of 2015, an estimated 415 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. This represents 8.3% of the adult population, with equal rates in both women and men. As of 2014, trends suggested the rate would continue to rise. Diabetes at least doubles a person's risk of early death. From 2012 to 2015, approximately 1.5 to 5.0 million deaths each year resulted from diabetes. The global economic cost of diabetes in 2014 was estimated to be US$612 billion. In the United States, diabetes cost $245 billion in 2012.

Browse All Tags